Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis. (Q43657074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

secondary progressive multiple sclerosis

9 November 2019

main subject

0 references

0 references

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

K Makhlouf

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Comabella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Imitola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

H L Weiner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

156-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

Blood lymphocyte beta-adrenergic receptors in multiple sclerosis

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Interferon beta in multiple sclerosis: is IL-12 suppression the key?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD40 signals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Monocytes in multiple sclerosis: phenotype and cytokine profile

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

The control of T cell responses by dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Regulation of IL-17, IFN-gamma and IL-10 in human CD8(+) T cells by cyclic AMP-dependent signal transduction pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

The role of IL-12 in the induction of organ-specific autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-1b therapeutic effects in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

Increased expression of high affinity IL-2 receptors and beta-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900322-8

7 January 2021

10.1016/S0165-5728(01)00322-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11431016%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference